Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 23.04.26
World IP Day 2026: keeping Europe on track for innovation
As Europe strives to compete globally in life sciences, predictable and robust IP incentives will determine whether tomorrow’s breakthroughs are developed...
Read Article -
Blog articles 22.04.26
The €240 billion leak: Why Europe’s health resilience starts with integrated obesity, diabetes and CVD...
Europe is treating the symptoms of a crisis while ignoring the drivers behind it. By the time an EU citizen is diagnosed with a cardiovascular complication,...
Read Article -
Blog articles 21.04.26
The escalating burden of non-communicable diseases demands new solutions
Managing the status quo is not an option – it is time to change how we fund and deliver health in Europe
Read Article -
Partner Event 07.05.26
Towards comprehensive cardiovascular health checks across Europe
Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances in treatment. Late diagnosis,...
View Event -
External Event 19.05.26
European Pharmaceutical Law Forum
The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical package, a growing maze of regulatory...
View Event -
External Event 03.06.26
European Conference on Rare Diseases and Orphan Products (ECRD) 2026
The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address...
View Event